Literature DB >> 23523419

Nutritional status, CT body composition measures and survival in ovarian cancer.

Michelle L Torres1, Lynn C Hartmann, William A Cliby, Kimberly R Kalli, Phillip M Young, Amy L Weaver, Carrie L Langstraat, Aminah Jatoi, Sanjeev Kumar, Andrea Mariani.   

Abstract

OBJECTIVE: Body composition measures (BCMs) are an important predictor of nutritional status in patients with cancer. Poor nutritional status is common in ovarian cancer (OC) and is a well-known variable that influences cancer treatment and outcome. We aim to establish the role of BCMs measured by computed tomography (CT) in predicting outcomes in patients with OC.
METHODS: We retrospectively searched our institutional database for patients with stage IIIC/IV OC who underwent surgery as primary treatment at Mayo Clinic between 1996 and 2005 and had adequate presurgical CT images available. For each patient, 1 axial CT image at the level of the 3rd lumbar vertebra was evaluated. Adipose and lean tissues were discriminated using commercially available software. Cox models were fit to evaluate the relationship between patient factors and overall survival (OS). Associations were summarized using hazard ratios (HRs) and corresponding 95% CIs.
RESULTS: A total of 82 patients were identified, with a median age of 68.4 years. OS at 1 and 5 years was 84.1% and 24.1%, respectively. Older age (P=.01), stage IV disease (P<.001), and subcutaneous and muscular fat<77.21cm(2) (P<.001) were independently associated with poor OS. Longer hospital stay was independently predicted by albumin≤3g/dL (P=.03), suboptimal surgery (P=.02), and subcutaneous and muscular fat<77.21cm(2) (P<.001). Surgical complications were independently predicted only by albumin≤3g/dL (P<.01).
CONCLUSIONS: CT BCMs, as indicators of nutritional status, are independent predictors of longer hospital stay and poor OS in patients with OC. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23523419     DOI: 10.1016/j.ygyno.2013.03.003

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  16 in total

Review 1.  The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint.

Authors:  Bette J Caan; Elizabeth M Cespedes Feliciano; Candyce H Kroenke
Journal:  Cancer Res       Date:  2018-04-15       Impact factor: 12.701

2.  Muscle radiodensity and mortality in patients with colorectal cancer.

Authors:  Candyce H Kroenke; Carla M Prado; Jeffrey A Meyerhardt; Erin K Weltzien; Jingjie Xiao; Elizabeth M Cespedes Feliciano; Bette J Caan
Journal:  Cancer       Date:  2018-05-24       Impact factor: 6.860

Review 3.  The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review.

Authors:  D J Gibson; S T Burden; B J Strauss; C Todd; S Lal
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

Review 4.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

5.  RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.

Authors:  Fabrizio Pin; Alexander J Jones; Joshua R Huot; Ashok Narasimhan; Teresa A Zimmers; Lynda F Bonewald; Andrea Bonetto
Journal:  J Bone Miner Res       Date:  2021-12-13       Impact factor: 6.390

6.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 7.  Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis.

Authors:  Sarah A Purcell; Sarah A Elliott; Candyce H Kroenke; Michael B Sawyer; Carla M Prado
Journal:  Curr Oncol Rep       Date:  2016-02       Impact factor: 5.075

8.  Weight change therapy as a potential treatment for end-stage ovarian carcinoma.

Authors:  Kuat Pernekulovich Oshakbayev; Kenneth Alibek; Igor Olegovich Ponomarev; Nurlybek Nurlanovich Uderbayev; Bibazhar Abayevna Dukenbayeva
Journal:  Am J Case Rep       Date:  2014-05-12

9.  Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study.

Authors:  Mette Ørskov; Maria Iachina; Rikke Guldberg; Ole Mogensen; Bente Mertz Nørgård
Journal:  BMJ Open       Date:  2016-04-21       Impact factor: 2.692

10.  Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.

Authors:  Iris J G Rutten; David P J van Dijk; Roy F P M Kruitwagen; Regina G H Beets-Tan; Steven W M Olde Damink; Toon van Gorp
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-03-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.